Impact of Antipsychotic Medications on Weight Gain and Eating Disorder-Related Psychopathology in Adult Inpatients with Anorexia Nervosa
Pharmacopsychiatry · 01.03.2025 · 58 (02) · 80-87
DOI: 10.1055/a-2436-9552 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmacopsychiatry, erschienen am 01.03.2025. Verfasst von Tabea Bauman und 4 weiteren Autor:innen. Beteiligte Einrichtung: Schoen Clinic Roseneck, Prien am Chiemsee, Germany. Hauptthemen laut MEDLINE: Antipsychotic Agents, Weight Gain, Anorexia Nervosa. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 42 Literaturangaben.
Abstract (Originalsprache)
Introduction
The impact of antipsychotic use on weight gain and eating disorder-related psychopathology in adult inpatients with anorexia nervosa (AN) is unclear.
Methods
Consecutively hospitalized adults with AN were retrospectively analyzed. Co-primary outcomes were body mass index (BMI) and weekly weight change. Secondary outcomes were Eating Disorder Inventory-2 (EDI-2) subscale scores ‘drive for thinness’ and ‘body dissatisfaction’. Admission-to-discharge changes were compared in patients continuing pre-admission antipsychotics (APcont), starting antipsychotics (APnew) and patients without psychopharmacotherapy (noMed) using linear mixed models. Sensitivity analyses were conducted in subgroups matched for age, length of stay, baseline BMI and baseline EDI-2 scores. Subgroups were also compared regarding BMI trajectories, using non-linear growth curve models. Within-group analyses compared weight gain before vs. after the median antipsychotic onset week.
Results
Of 775 adult inpatients (mean length of stay =103.5±48.0 days), 21.7% received antipsychotics (APcont =7.7%; APnew=13.9%), i. e., olanzapine (n=127, dose =5.5±3.1 mg/day) or quetiapine (n=41, dose=100.0±97.7 mg/day), while 78.3% did not receive any medication. Comparing all three groups, a significant time×group interaction was found for noMed and APnew vs. APcont (p=0.011), but this effect disappeared when comparing matched subgroups. However, in matched subgroups (n=54 each) APnew showed steeper weight gain vs. APcont both overall (p=0.011) and after median antipsychotic initiation (5.8±5.0 weeks) (p≤0.001). No significant group differences emerged in EDI-2 subscale scores.
Discussion
In this naturalistic study, 22% of adult inpatients received antipsychotics. However, neither weight gain nor AN-related psychopathology changed differently in patients treated with vs. without antipsychotics. Newly initiated antipsychotic treatment vs. continuation from pre-admission had better weight gain outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Schoen Clinic Roseneck, Prien am Chiemsee, Germany.
- Clinical Child and Adolescent Psychology and Psychotherapy, Department of Psychology, University of Regensburg, Regensburg, Germany.
- Department of Psychiatry and Psychotherapy, Ludwig-Maximilians-University Munich, Munich, Germany.
- Department of Child and Adolescent Psychiatry, Charité-Universitätsmedizin Berlin, Berlin, Germany.
- Department of Psychiatry and Molecular Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York, USA.
- Department of Psychiatry, Zucker Hillside Hospital, Glen Oaks, New York, USA.
Zitieren
APA
Bauman, T., Kolar, D. R., Correll, C. U., Haas, V., & Voderholzer, U. (2025). Impact of Antipsychotic Medications on Weight Gain and Eating Disorder-Related Psychopathology in Adult Inpatients with Anorexia Nervosa. Pharmacopsychiatry, 58(02), 80-87. https://doi.org/10.1055/a-2436-9552
Vancouver
Bauman T, Kolar DR, Correll CU, Haas V, Voderholzer U. Impact of Antipsychotic Medications on Weight Gain and Eating Disorder-Related Psychopathology in Adult Inpatients with Anorexia Nervosa. Pharmacopsychiatry. 2025;58(02):80-87. doi:10.1055/a-2436-9552
BibTeX
@article{Bauman2025,
author = {Bauman, Tabea and Kolar, David R and Correll, Christoph U and Haas, Verena and Voderholzer, Ulrich},
title = {Impact of Antipsychotic Medications on Weight Gain and Eating Disorder-Related Psychopathology in Adult Inpatients with Anorexia Nervosa},
journal = {Pharmacopsychiatry},
year = {2025},
volume = {58},
number = {02},
pages = {80--87},
doi = {10.1055/a-2436-9552}
}
EUVIMED